Insider Shareholders with Direct Ownership of Poseida Therapeutics, Inc. (PSTX)
This section provides a comprehensive overview of the insiders with direct ownership of Poseida Therapeutics, Inc. (PSTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Poseida Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pharma Ag Novartis
> 10% Shareholder |
5,908,089 | 0 | 5,908,089 $56.1 Million | 1 |
Jul 14, 2020
Added 50.0%
|
|
Eric Ostertag
Director |
563,241 | 105,731 | 827,320 $7.86 Million | 10 |
Feb 01, 2023
Reduced 1.4%
|
|
Brent Warner
President, Gene Therapy |
481,396 | 62,356 | 419,040 $3.98 Million | 5 |
Mar 01, 2024
Reduced 7.86%
|
|
Matthew A. Spear
Chief Medical Officer |
123,485 | 12,000 | 111,485 $1.06 Million | 14 |
Mar 01, 2022
Added 30.96%
|
|
Kerry D. Ingalls
Chief Operating Officer |
55,000 | 0 | 55,000 $522,500 | 3 |
Mar 16, 2022
Added 5.17%
|
| 58,950 | 58,950 | 0 $0 | 3 |
Jan 08, 2025
Reduced 100.0%
|
|
|
Malin Life Sciences Holdings Ltd
> 10% Shareholder |
2,647,548 | 11,835,673 | 0 $0 | 14 |
Jan 08, 2025
Reduced 100.0%
|
| 78,600 | 78,600 | 0 $0 | 4 |
Jan 08, 2025
Reduced 100.0%
|
|
| 58,950 | 58,950 | 0 $0 | 4 |
Jan 08, 2025
Reduced 100.0%
|
|
| 58,950 | 58,950 | 0 $0 | 4 |
Jan 08, 2025
Reduced 100.0%
|
|
|
Kristin Yarema
President and CEO |
606,836 | 615,836 | 0 $0 | 3 |
Jan 08, 2025
Reduced 100.0%
|
|
Johanna Mylet
Chief Financial Officer |
233,959 | 277,266 | 0 $0 | 8 |
Jan 08, 2025
Reduced 100.0%
|
|
Harry J Leonhardt
GC & Chief Compliance Officer |
223,515 | 244,269 | 0 $0 | 6 |
Jan 08, 2025
Reduced 100.0%
|
|
Mark J Gergen
President and CEO |
811,786 | 833,177 | 0 $0 | 12 |
Jan 08, 2025
Reduced 100.0%
|
| 58,950 | 68,950 | 0 $0 | 4 |
Jan 08, 2025
Reduced 100.0%
|
|
| 58,950 | 58,950 | 0 $0 | 4 |
Jan 08, 2025
Reduced 100.0%
|
|
|
Syed Ali Aamir Rizvi
Chief Medical Officer |
185,000 | 185,000 | 0 $0 | 2 |
Jan 08, 2025
Reduced 100.0%
|